¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"ossification point, secondary"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
  • iliac point
    Àå°ñÁ¡.
  • incisal point angle
    Àý´Ü¿¬Ã·°¢(ôîÓ®æÞôÓÊÇ).
  • indifferent point
    Á߸³Á¡(ñéí¡ïÇ).
  • infinite point
    ¹«ÇÑ¿øÁ¡(ÊÙËôËø).
  • inversion point
    ¿ªÀü¿Âµµ.
  • isoelectric point
    µîÀü¾ÐÁ¡
  • isoelectric point
    µîÀüÁ¡(Ôõï³ïÇ).
  • isolated point
    °í¸³Á¡(͵í¡ïÇ).
  • itchy point
    ¼Ò¾çÁ¡(¡­ïÇ) ¡ìÇǺÎÇ¥¸éÀÇ¡í
  • jugomaxillary point
    Çù»ó¾ÇÁ¡(Çù»ó¾ÇÁ¡).
  • jugomaxillary point
    Çù»ó¾ÇÁ¡(úúß¾äÉïÇ).
  • lacrimal point
    ´©Á¡(רïÇ), ´«¹°±¸¸Û.
  • leak-point pressure
    ´©ÃâÁ¡¾Ð·Â
  • leaking point
    »ùÁ¡, ´©ÃâÁ¡
  • lower yield point
    ÇÏÇ׺¹Á¡(ù»ú¢ÜÑïÇ).
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 8
ap anteroposterior; attachment point
bb Bolton point; both bones
Bo Bolton point
bp base pair; bed pan; boiling point
CPD calcium pyrophosphate deposition; cephalopelvic disproportion; cerebelloparenchymal disorder; childh...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 8
mbr major break point region
P.I. point
TP tender point
TrP trigger point
TP turning point
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 9 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • tender point
    ¾ÐÅëÁ¡
    ·ù¸¶Æ¼ÁòÇп¡¼­ »ç¿ëµÇ´Â ¿ë¾î·Î¼­ ƯÀÌÇÏ°Ô ¼¶À¯ ±ÙÅë¿¡¼­ ÃËÁø¿¡ ´ëÇØ ÅëÁõÀ» ³ªÅ¸³¾ ¼ö ÀÖ´Â 9½ÖÀÇ ÇØºÎÇÐÀû À§Ä¡
  • trapezius trigger point
    ½Â¸ð±Ù ¹ßÅëÁ¡
  • trigger point
    ¹ßÅëÁ¡, À¯¹ßÁ¡
    ÀÚ±ØÀ» ¹ÞÀ¸¸é ¹Ýº¹ÀûÀ¸·Î ±Þ¼º ½Å°æÅ뼺 ÅëÁõÀ̳ª ÀüÀÌµÈ ±Ù°ñ°Ý¼º ÅëÁõÀ» À¯¹ßÇÏ´Â ÇǺγª ±ÙÀ°ÀÇ ¸ðµç ºÎÀ§ÀÌ´Ù. ÀÌ ¿ë¾î´Â 3Â÷ ½Å°æÅëÀ̳ª ±Ù¸· ÅëÁõ ¸ðµÎ¿¡¼­ »ç¿ëµÈ´Ù. myofascial trigger
  • trigger point injection
    ¹ßÅëÁ¡ ÁÖ»ç
  • trigger point pain
    ¹ßÅëÁ¡ µ¿Åë
  • triple point
    »ïÁß Á¡
  • two-point discrimination testing
    µÎ Á¡ ½Äº°´É °Ë»ç
  • yield point
    Ç׺¹Á¡
    Àç·á¿¡ ÇÏÁßÀ» °¡ÇØ Â÷Ãû ´Ã·Á¼­ ºñ·Ê Çѵµ¸¦ ³Ñ´Â ÀÀ·ÂÀ» ÁÖ¾úÀ» ¶§ ÀÀ·ÂÀº Áõ°¡ÇÏÁö ¾Ê°í ¿Ö·ÂÀÌ ±Þ°ÝÈ÷ Áõ°¡ÇÏ´Â Á¡¿¡ À̸£°Ô µÈ´Ù. Áï ¿©Áö²¯ ºñ±³ÀûÀ¸·Î ź¼ºÀûÀ̵ç Àç·á°¡ ±Þ°ÝÈ÷ ¼Ò¼º º¯ÇüÀ» ½ÃÀÛÇϴµ¥ À̶§ÀÇ ÀÀ·ÂÀ» Ç׺¹Á¡À̶ó°í ÇÑ´Ù.
  • Ziemssen's motor point
    ÁöÀÓ¼¾ ¿îµ¿½Å°æ Á¡
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
jugal point A craniometric point at the union of the temporal and frontal processes of the zygomatic bone.
Synonym: jugal point.
(05 Mar 2000)
far point That point in conjugate focus with the retina when the eye is not accommodating.
Synonym: punctum remotum.
(05 Mar 2000)
far point of convergence The point to which the visual lines are directed when convergence is at rest.
(05 Mar 2000)
far point of eye <microscopy> For the normal eye, the far point is at infinity. The rays of light from an infinitely distant point source are parallel and can be focused with the accommodation muscles of the eye entirely relaxed.
See: accommodation, near point of the eye.
(05 Aug 1998)
zygomaxillary point A craniometric point located externally at the lowest extent of the zygomaticomaxillary suture.
Synonym: key ridge, zygomaxillary point.
(05 Mar 2000)
flash point The lowest temperature at which vapors of a liquid may be ignited by a flame.
(05 Mar 2000)
focal point Location of an organism, for fish, usually the position of the snout. Habitat measurements made at that position (depth, water velocity, etc.) are focal point measurements.
(09 Oct 1997)
freezing point <physics> The temperature at which a liquid solidifies.
(05 Mar 2000)
leak point pressure Storage pressure in bladder at which leakage occurs passively, usually in patients with neuropathic bladder.
(05 Mar 2000)
fusing point See: fusion temperature (wire method).
(05 Mar 2000)
lower alveolar point In craniometrics, the apex of the septum between the mandibular central incisors.
Synonym: lower alveolar point.
(05 Mar 2000)
CS2 secondary alkylsulfohydrolase <enzyme> From comamonas terrigena
Registry number: EC 3.1.6.-
Synonym: cs2 sa sulfohydrolase
(26 Jun 1999)
protein structure, secondary The stage in the development of protein structure in which regular hydrogen-bond interactions within contiguous stretches of polypeptide chain give rise to alpha helices and beta sheets. This is the first folding level of protein building.
(12 Dec 1998)
secondary Second or inferior in order of time, place or importance, derived from or consequent to a primary event or thing.
Origin: L. Secundarius, secundus = second
(18 Nov 1997)
secondary abdominal pregnancy A condition in which the embryo or foetus continues to grow in the abdominal cavity after its expulsion from the fallopian tube or other seat of its primary development.
Synonym: abdominocyesis.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 8
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 8
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 8
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 8
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 8
ÅëÇÕ°Ë»ö ¿Ï·á